In patient with symptomatic peripheral arterial disease who had undergone lower-extremity revascularization, does rivaroxaban 2.5 mg twice daily plus aspirin reduce the composite risk of acute limb ischemia, major amputation for vascular causes, myocardial infarction, ischemic stroke or cardiovascular death compared to aspirin alone while being safe?

被引：0

作者：

Lanthier, L. ^{[1
]}

Huard, G. ^{[1
]}

Plourde, M. -E. ^{[1
]}

Cauchon, M. ^{[2
]}

机构：

[1] Univ Sherbrooke, Sherbrooke, PQ, Canada

[2] Univ Laval, Quebec City, PQ, Canada

来源：

REVUE DE MEDECINE INTERNE | 2020年 / 41卷 / 08期

关键词：

Peripheral arterial disease; Treatment; Rivaroxaban;

D O I：

10.1016/j.revmed.2020.07.004

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：571 / 572

页数：2